General characteristics of participants at baseline.
COPD, test-related adverse
CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COPD, DISEASE
Data are reported as number and percent or median (interquartile range). TIE: timed inspiratory effort; TPT: T-piece trial; APACHE II: Acute Physiology and Chronic Health Evaluation II; MV: mechanical ventilation; ICU: intensive care unit; COVID-19: SARS-CoV-2 disease; COPD: chronic obstructive pulmonary disease.Data referring to clinical and laboratory parameters on the day of the first decision test and test-related adverse events are shown in 